IRD Opus Genetics, Inc. - Common Stock
$3,88
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$1–$6
59% of range
Analystenbewertung
BUY
23 analysts
Kursziel
$11
+173% upside
P/E (TTM)
-5.0
ROE
-302.2%
Nettogewinnmarge
-349.3%
IRD Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$3.88
Marktkapitalisierung
$277M
P/E (TTM)
-5.0
EPS (TTM)
$-0.80
Umsatz (TTM)
$14M
Dividendenrendite
—
ROE
-302.2%
Verschuldungsgrad
0.1
52W-Spanne
$1 – $6
IRD Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$14M
2020-12-31
→
2025-12-31
EPS
$-0.80
2020-12-31
→
2025-12-31
Freier Cashflow
—
2020-12-31
→
2020-12-31
Margen
-349.3%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
IRD
Peer-Median
P/E (TTM)
-5.0
4.8
P/S (TTM) (K/V (TTM))
19.5
25.4
P/B (K/B)
18.1
1.8
EV / EBITDA
-6.0
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
IRD
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-271.9%
—
Net Profit Margin (Nettogewinnmarge)
-349.3%
-892.4%
ROA
-113.9%
-40.4%
ROE
-302.2%
-52.2%
ROIC
-234.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
IRD
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.1
0.0
Current Ratio (Liquiditätsgrad)
6.4
6.5
Quick Ratio
6.1
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
IRD
Peer-Median
Revenue YoY (Umsatz YoY)
29.1%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
-29.1%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
IRD
Peer-Median
IRD Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
23 Analysten
- Starker Kauf 6 26,1%
- Kauf 16 69,6%
- Halten 1 4,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
18 Analysten · 2026-08-15
Median
$10.00
← Unter allen Zielen
$3.88
Tief
$8.00
Hoch
$16.00
Median-Ziel
$10.00
+157,7%
Mittelwert-Ziel
$10.61
+173,5%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.13%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.14 | $-0.16 | 0.02% |
| 31. März 2026 | $-0.75 | $-0.14 | -0.61% |
| 31. Dezember 2025 | $-0.29 | $-0.12 | -0.17% |
| 30. September 2025 | $-0.25 | $-0.13 | -0.12% |
| 30. Juni 2025 | $-0.12 | $-0.21 | 0.09% |
| 31. März 2025 | $-0.24 | $-0.25 | 0.01% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | — |
| AGEN | $111M | — | 10.4% | -2.7% | 1.0% | — |
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | — |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | — |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | — |
| AVXL | $771M | -16.5 | -36.1% | -991.4% | -47.7% | — |
| ELDN | $114M | -2.9 | — | — | -69.4% | — |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $11M | $19M | $40M | $589.0K | $0 | · | · | · | · | · | · | |
| R&D Expense | · | · | · | · | · | · | $5M | $13M | $11M | $10M | $12M | $7M | |
| SG&A Expense | $22M | $18M | $12M | $7M | $8M | $3M | $2M | $7M | $7M | $6M | $6M | $6M | |
| Operating Expenses | $53M | $73M | $30M | $22M | $23M | $20M | $4M | $21M | $17M | $16M | $18M | $13M | |
| Operating Income | $-39M | $-62M | $-11M | $18M | $-23M | $-20M | $-4M | $-21M | $-17M | $-16M | $-18M | $-13M | |
| Interest Expense | · | · | $0 | $9.0K | $2.0K | $7M | $1M | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | $313.7K | $254.3K | $207.0K | $118.6K | $103.3K | $133.9K | |
| Other Non-op | $2M | $4M | $2M | $-14.0K | $-157.0K | $9.0K | $-68.0K | $6M | $-8M | $7M | $4M | $-5M | |
| Pretax Income | $-50M | $-58M | $-10M | $18M | $-57M | $-25M | $-6M | · | · | · | · | · | |
| Income Tax | $0 | $0 | $12.0K | $315.0K | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-50M | $-58M | $-10M | $18M | $-57M | $-25M | $-6M | $-14M | $-25M | $-9M | $-14M | $-19M | |
| EPS (Basic) | $-0.80 | $-2.15 | $-0.46 | $0.90 | $-3.82 | $-5.28 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.80 | $-2.15 | $-0.46 | $0.87 | $-3.82 | $-5.28 | · | · | · | · | · | · | |
| Shares (Basic) | 62,221,901 | 26,715,526 | 21,589,821 | 19,931,080 | 14,852,745 | 4,661,110 | · | · | · | · | · | · | |
| Shares (Diluted) | 62,221,901 | 26,715,526 | 21,589,821 | 20,597,212 | 14,852,745 | 4,661,110 | · | · | · | · | · | · | |
| EBITDA | $-39M | $-62M | $-11M | $18M | $-23M | $-20M | · | $-21M | $-17M | $-16M | $-18M | $-13M |
Bilanz 25
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45M | $30M | $51M | $43M | $25M | · | $12M | $9M | $9M | $12M | $10M | $10M | |
| Short-term Investments | $0 | $2.0K | $15.0K | $49.0K | $219.0K | $0 | $3M | $6M | $18M | $9M | $13M | $23M | |
| Receivables | $2M | $4M | $926.0K | $1M | $0 | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $515.0K | $1M | $1M | $1M | $1M | $149.0K | $1M | $1M | $608.5K | $1M | $731.0K | |
| Other Current Assets | · | · | $102.0K | $80.0K | $71.0K | $26.0K | $5.0K | $555.4K | $510.6K | $429.0K | $720.6K | $361.2K | |
| Current Assets | $50M | $37M | $54M | $49M | $26M | $18M | $2M | $16M | $28M | $21M | $25M | $33M | |
| PP&E (Net) | $199.0K | $252.0K | $0 | $6.0K | $10.0K | $14.0K | $22.0K | $112.5K | $121.5K | $88.7K | $112.9K | $78.1K | |
| PP&E (Gross) | · | · | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $821.6K | $833.3K | $758.1K | $749.5K | $687.2K | |
| Accum. Depreciation | · | · | $25.0K | $19.0K | $15.0K | $11.0K | $3.0K | $709.1K | $711.8K | $669.5K | $636.6K | $609.1K | |
| Total Assets | $50M | $37M | $54M | $49M | $26M | $18M | $2M | $16M | $28M | $21M | $25M | $34M | |
| Accounts Payable | $3M | $3M | $2M | $1M | $2M | $1M | $342.0K | $3M | $3M | $2M | $3M | $2M | |
| Accrued Liabilities | $4M | $8M | $2M | $2M | $2M | $2M | $621.0K | · | · | · | · | · | |
| Short-term Debt | · | · | · | $0 | $538.0K | $0 | · | · | · | · | · | · | |
| Current Liabilities | $8M | $11M | $4M | $3M | $4M | $3M | $9M | $3M | · | · | · | · | |
| Capital Leases | · | · | · | · | · | · | $63.6K | · | · | · | · | · | |
| Total Liabilities | $35M | $11M | $4M | $3M | $4M | $31M | $9M | $5M | $12M | $4M | $6M | $7M | |
| Total Debt | $1M | · | · | $0 | $538.0K | · | · | · | · | · | · | · | |
| Common Stock | $7.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | $0 | $312 | $3.2K | $2.4K | $19.7K | $17.8K | |
| Paid-in Capital | $204M | $146M | $131M | $118M | $112M | $19M | $495.0K | · | · | · | · | · | |
| Retained Earnings | $-189M | $-139M | $-81M | $-71M | $-89M | $-33M | $-8M | $-155M | $-140M | $-115M | $-106M | $-91M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $128.4K | |
| AOCI | · | · | · | · | · | · | $2.1K | $-17.8K | $-56.9K | $-6.1K | $-18.0K | $-33.6K | |
| Stockholders' Equity | $15M | $7M | $50M | $46M | $22M | $-13M | $-8M | $-2M | $17M | $17M | $19M | $27M | |
| Liabilities + Equity | $50M | $37M | $54M | $49M | $26M | $18M | $2M | $16M | $28M | $21M | $25M | $34M | |
| Shares Outstanding | 69,894,507 | 31,574,657 | 23,977,491 | 20,861,315 | 18,845,828 | 10,882,495 | 2,852,485 | 3,122,843 | 2,639,319 | 23,736,878 | 19,741,378 | 17,836,652 |
Cashflow 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $41.0K | $48.2K | $42.4K | $32.9K | $27.5K | $28.3K | |
| Stock-based Comp | $3M | $3M | $4M | $2M | $2M | $2M | $308.0K | $1M | $1M | $1M | $1M | $608.8K | |
| Operating Cash Flow | $-35M | $-26M | $-1M | $14M | $-19M | $-7M | $-4M | $-19M | $-15M | $-13M | $-17M | $-11M | |
| CapEx | · | · | · | · | · | $0 | $25.0K | · | · | · | · | · | |
| Investing Cash Flow | $0 | $1M | $0 | $0 | $-100.0K | $539.0K | $-25.0K | $12M | $-9M | · | · | · | |
| Stock Issued | $6M | $4M | $9M | $4M | $28M | $0 | $8M | $7M | $17M | · | $1M | · | |
| Net Stock Activity | $6M | $4M | $9M | $4M | $28M | · | · | $7M | · | · | · | · | |
| Financing Cash Flow | $50M | $4M | $9M | $4M | $28M | $21M | $5M | $7M | $22M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $-154.9K | $-3M | $1M | $373.2K | $-9M | |
| Taxes Paid | $0 | $0 | $344.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-7M | · | · | · | · | · | · | |
| Levered FCF | · | · | · | · | · | $-14M | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -271.9% | -564.7% | -55.5% | 45.7% | -3854.8% | · | · | · | · | · | · | · | |
| Net Margin | -349.3% | -523.4% | -52.4% | 44.9% | -9625.3% | · | · | · | · | · | · | · | |
| Pretax Margin | -349.3% | -523.4% | -52.4% | 45.7% | -9625.3% | · | · | · | · | · | · | · | |
| EBITDA Margin | -271.9% | -564.7% | -55.5% | 45.7% | -3854.8% | · | · | · | · | · | · | · | |
| ROA | -113.9% | -126.7% | -19.4% | 47.7% | -259.1% | -253.0% | · | -64.8% | -102.6% | -40.6% | -49.3% | -69.8% | |
| ROE | -302.2% | -280.5% | -19.9% | 61.6% | -265.0% | 215.2% | · | -169.3% | -149.6% | -51.9% | -63.4% | -94.5% | |
| ROIC | -234.3% | -923.2% | -21.2% | 38.7% | -99.8% | 148.3% | · | · | · | · | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.4 | 3.2 | 13.3 | 17.8 | 6.8 | 5.5 | · | · | · | · | · | · | |
| Quick Ratio | 6.1 | 3.0 | 12.7 | 16.0 | 0.1 | · | · | · | · | · | · | · | |
| Debt / Equity | 0.1 | · | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | 2025.1 | -11352.5 | -2.9 | · | · | · | · | · | · |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.4 | 1.1 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 5.1 | 4.9 | 17.1 | 61.4 | · | · | · | · | · | · | · | · |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 29.1% | -42.3% | -52.2% | 6665.7% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -29.1% | 165.2% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14M | $11M | $19M | $40M | $589.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-50M | $-58M | $-10M | $18M | $-57M | $-25M | $-6M | $-14M | $-25M | $-9M | $-14M | $-19M | |
| Market Cap | $140M | $38M | $72M | $74M | $70M | $71M | · | $1.68B | $3.08B | $15.95B | $34.11B | $59.89B | |
| Enterprise Value | $97M | · | · | $31M | · | · | · | · | · | · | · | · | |
| P/E | -2.5 | -0.6 | -6.5 | 4.1 | -1.0 | -1.2 | -30.6 | -178.6 | -93.2 | · | · | · | |
| P/S | 9.9 | 3.4 | 3.8 | 1.8 | 119.3 | · | · | · | · | · | · | · | |
| P/B | 9.2 | 5.6 | 1.4 | 1.6 | 3.2 | -5.2 | · | 158.6 | 183.4 | 935.1 | 1816.9 | 2253.3 | |
| P / Tangible Book | 9.2 | 5.6 | 1.4 | 1.6 | 3.2 | · | · | · | · | · | · | · | |
| P / Cash Flow | -4.0 | -1.5 | -64.9 | 5.1 | -3.6 | -10.4 | · | -88.9 | -199.5 | -1205.9 | -1966.0 | -5424.5 | |
| P / FCF | · | · | · | · | · | -10.4 | · | · | · | · | · | · | |
| EV / EBITDA | -2.5 | · | · | 1.7 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 6.8 | · | · | 0.8 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -39.8% | -180.7% | -15.3% | 24.6% | -102.4% | -81.4% | -3.3% | -0.56% | -1.1% | · | · | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $755.0K | $2M | $4M | $3M | $3M | $4M | $4M | $4M | $1M | $2M | $2M | $12M | $4M | $2M | $40M | $0 | |
| SG&A Expense | $6M | $6M | $5M | $5M | $6M | $6M | $7M | $3M | $3M | $5M | $3M | $2M | $4M | $2M | $2M | $2M | |
| Operating Expenses | $17M | $17M | $15M | $11M | $12M | $14M | $42M | $12M | $9M | $9M | $7M | $6M | $9M | $8M | $6M | $5M | |
| Operating Income | $-16M | $-14M | $-11M | $-8M | $-9M | $-10M | $-38M | $-8M | $-8M | $-8M | $-5M | $6M | $-5M | $-6M | $34M | $-5M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Other Non-op | $2M | $844.0K | $703.0K | $450.0K | $534.0K | $302.0K | $3M | $483.0K | $563.0K | $602.0K | $613.0K | $456.0K | $428.0K | $340.0K | $46.0K | $7.0K | |
| Pretax Income | $-8M | $-66M | $-17M | $-17M | $-7M | $-8M | $-35M | $-8M | $-8M | $-7M | $-5M | $6M | $-5M | $-6M | $34M | $-5M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-2.0K | $14.0K | $0 | $0 | $315.0K | $0 | |
| Net Income | $-8M | $-66M | $-17M | $-17M | $-7M | $-8M | $-35M | $-8M | $-8M | $-7M | $-5M | $6M | $-5M | $-6M | $34M | $-5M | |
| EPS (Basic) | $-0.08 | $-0.75 | $-0.19 | $-0.25 | $-0.12 | $-0.24 | $-1.27 | $-0.29 | $-0.30 | $-0.29 | $-0.20 | $0.26 | $-0.24 | $-0.28 | $1.72 | $-0.22 | |
| EPS (Diluted) | $-0.14 | $-0.75 | $-0.19 | $-0.25 | $-0.12 | $-0.24 | $-1.27 | $-0.29 | $-0.30 | $-0.29 | $-0.19 | $0.25 | $-0.24 | $-0.28 | $1.69 | $-0.22 | |
| Shares (Basic) | 95,483,280 | 86,891,352 | -105,676,298 | 70,636,887 | 63,376,392 | 33,884,920 | -49,777,294 | 26,145,080 | 25,827,265 | 24,520,475 | -41,756,241 | 21,446,648 | 20,959,807 | 20,939,607 | -38,958,183 | 20,498,229 | |
| Shares (Diluted) | 111,384,011 | 86,891,352 | -105,676,298 | 70,636,887 | 63,376,392 | 33,884,920 | -49,777,294 | 26,145,080 | 25,827,265 | 24,520,475 | -42,715,588 | 22,405,995 | 20,959,807 | 20,939,607 | -38,292,051 | 20,498,229 | |
| EBITDA | $-16M | $-14M | · | $-8M | $-9M | $-10M | · | $-8M | $-8M | $-8M | · | $6M | $-5M | $-6M | · | $-5M |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $60M | $45M | $31M | $32M | $42M | $30M | $37M | $41M | $47M | $51M | $42M | $40M | $39M | $43M | $14M | |
| Short-term Investments | · | · | $0 | $0 | $0 | $1.0K | $2.0K | $3.0K | $5.0K | $5.0K | $15.0K | $11.0K | $22.0K | $22.0K | $49.0K | $101.0K | |
| Receivables | $1M | $2M | $2M | $3M | $3M | $3M | $4M | $2M | $1M | $2M | $926.0K | $10M | $135.0K | $3M | $1M | · | |
| Prepaid Expense | $2M | $4M | $2M | $815.0K | $1M | $1M | $515.0K | $429.0K | $1M | $2M | $1M | $484.0K | $732.0K | $1M | $1M | $605.0K | |
| Other Current Assets | · | · | · | · | · | · | · | $86.0K | $87.0K | $89.0K | · | $51.0K | $45.0K | $78.0K | $80.0K | $61.0K | |
| Current Assets | $93M | $67M | $50M | $36M | $38M | $48M | $37M | $40M | $45M | $52M | $54M | $54M | $43M | $45M | $49M | $15M | |
| PP&E (Net) | $172.0K | $186.0K | $199.0K | $212.0K | $226.0K | $239.0K | $252.0K | $0 | $0 | $0 | $0 | $3.0K | $4.0K | $5.0K | $6.0K | $7.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $25.0K | $25.0K | $25.0K | · | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | $25.0K | $25.0K | $25.0K | · | $22.0K | $21.0K | $20.0K | $19.0K | $18.0K | |
| Total Assets | $93M | $67M | $50M | $36M | $39M | $48M | $37M | $40M | $45M | $52M | $54M | $54M | $43M | $45M | $49M | $15M | |
| Accounts Payable | $2M | $4M | $3M | $2M | $1M | $2M | $3M | $844.0K | $634.0K | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Accrued Liabilities | · | · | $4M | · | · | · | $8M | $5M | $3M | $4M | $2M | $2M | $3M | $2M | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $8M | $9M | $8M | $29M | $20M | $24M | $11M | $6M | $4M | $6M | $4M | $4M | $6M | $4M | $3M | $3M | |
| Total Liabilities | $106M | $88M | $35M | $30M | $21M | $24M | $11M | $6M | $4M | $6M | $4M | $4M | $6M | $4M | $3M | $3M | |
| Long-term Debt | $35M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | $1M | · | $1M | $1M | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $8.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $249M | $208M | $204M | $178M | $172M | $152M | $146M | $138M | $137M | $135M | $131M | $127M | $120M | $119M | $118M | $117M | |
| Retained Earnings | $-262M | $-254M | $-189M | $-172M | $-155M | $-147M | $-139M | $-104M | $-96M | $-89M | $-81M | $-77M | $-82M | $-77M | $-71M | $-105M | |
| Stockholders' Equity | $-13M | $-46M | $15M | $6M | $17M | $5M | $7M | $34M | $41M | $46M | $50M | $50M | $38M | $41M | $46M | $12M | |
| Liabilities + Equity | $93M | $67M | $50M | $36M | $39M | $48M | $37M | $40M | $45M | $52M | $54M | $54M | $43M | $45M | $49M | $15M | |
| Shares Outstanding | 82,647,946 | 71,402,472 | 69,894,507 | 64,544,096 | 59,908,055 | 45,483,823 | 31,574,657 | 26,198,444 | 25,979,038 | 25,085,592 | 23,977,491 | 22,610,131 | 20,985,784 | 20,947,830 | 20,861,315 | 20,801,506 |
Cashflow 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $774.0K | $816.0K | $896.0K | $913.0K | $795.0K | $776.0K | $806.0K | $985.0K | $711.0K | $573.0K | $1M | $804.0K | $424.0K | $493.0K | |
| Operating Cash Flow | $-12M | $-13M | $-10M | $-6M | $-10M | $-9M | $-7M | $-5M | $-7M | $-6M | $5M | $-3M | $989.0K | $-4M | $29M | $-4M | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stock Issued | $0 | $2M | $179.0K | $5M | $0 | $409.0K | $0 | $456.0K | $2M | $2M | $4M | $5M | · | · | · | · | |
| Net Stock Activity | · | $2M | · | · | · | $409.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $41M | $28M | $24M | $5M | $906.0K | $20M | $-83.0K | $353.0K | $2M | $2M | $4M | $5M | $0 | $0 | $-12.0K | $1M | |
| Net Change in Cash | $29M | $15M | · | · | $-9M | $11M | · | · | · | · | · | · | · | · | · | · | |
| Taxes Paid | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $26.0K | $318.0K | $0 | $0 | $0 | $0 |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2182.8% | -665.9% | · | -269.9% | -309.0% | -227.2% | · | -207.1% | -748.9% | -450.5% | · | 53.5% | -146.7% | -350.5% | · | · | |
| Net Margin | -1072.6% | -3038.2% | · | -566.9% | -257.5% | -187.5% | · | -194.6% | -698.3% | -415.3% | · | 46.6% | -135.0% | -331.1% | · | · | |
| Pretax Margin | -1072.6% | -3038.2% | · | -566.9% | -257.5% | -187.5% | · | -194.6% | -698.3% | -415.3% | · | 46.7% | -135.0% | -331.1% | · | · | |
| EBITDA Margin | -2182.8% | -665.9% | · | -269.9% | -309.0% | -227.2% | · | -207.1% | -748.9% | -450.5% | · | 53.5% | -146.7% | -350.5% | · | · | |
| ROA | -12.3% | -114.0% | · | -45.6% | -17.8% | -16.4% | · | -15.9% | -17.6% | -14.6% | · | 16.2% | -16.2% | -17.6% | · | -24.0% | |
| ROE | -360.9% | 321.5% | · | -86.7% | -25.5% | -32.0% | · | -17.8% | -19.8% | -16.3% | · | 17.9% | -19.0% | -19.8% | · | -27.9% | |
| ROIC | 126.9% | 32.2% | · | -118.1% | -48.2% | -195.7% | · | -23.4% | -20.5% | -16.7% | · | 12.7% | -14.3% | -14.9% | · | -38.2% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.2 | 7.1 | · | 1.2 | 1.9 | 2.0 | · | 6.6 | 10.7 | 9.0 | · | 13.9 | 7.5 | 10.9 | · | 5.4 | |
| Quick Ratio | 11.8 | 6.6 | · | 1.2 | 1.8 | 1.9 | · | 6.3 | 10.2 | 8.5 | · | 13.4 | 7.0 | 10.1 | · | 5.2 | |
| Debt / Equity | · | -0.0 | · | 0.2 | 0.1 | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| LT Debt / Equity | · | -0.0 | · | 0.2 | 0.1 | · | · | · | · | · | · | · | · | · | · | · |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.3 | 0.1 | 0.1 | · | 0.0 | |
| Receivables Turnover | 0.3 | 0.9 | · | 1.3 | 1.2 | 1.7 | · | 0.6 | 1.5 | 0.7 | · | 2.4 | 39.7 | 1.2 | · | · |
Bewertung (TTM) 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $12M | · | $14M | $12M | $11M | · | $19M | $18M | $19M | · | $17M | $5M | $2M | · | $489.0K | |
| Net Income TTM | $-99M | $-99M | · | $-41M | $-31M | $-31M | · | $-17M | $-14M | $-12M | · | $-10M | $-20M | $-22M | · | $-20M | |
| Market Cap | $340M | $325M | · | $106M | $56M | $45M | · | $34M | $40M | $50M | · | $76M | $91M | $79M | · | $42M | |
| Enterprise Value | · | $266M | · | $77M | $25M | · | · | · | · | · | · | · | · | · | · | $28M | |
| P/E | -3.3 | -3.3 | · | -1.8 | -1.0 | -0.9 | · | -2.1 | -2.6 | -3.6 | · | -6.8 | -4.4 | -3.4 | · | -1.9 | |
| P/S | 38.3 | 26.0 | · | 7.5 | 4.6 | 4.0 | · | 1.8 | 2.2 | 2.6 | · | 4.4 | 16.8 | 44.9 | · | 85.5 | |
| P/B | -26.2 | -7.1 | · | 17.8 | 3.2 | 8.8 | · | 1.0 | 1.0 | 1.1 | · | 1.5 | 2.4 | 1.9 | · | 3.5 | |
| P / Tangible Book | · | · | · | 17.8 | 3.2 | 8.8 | · | 1.0 | 1.0 | 1.1 | · | 1.5 | 2.4 | 1.9 | · | 3.5 | |
| P / Cash Flow | · | -25.5 | · | · | · | -5.0 | · | · | · | -8.8 | · | · | · | -21.5 | · | · | |
| EV / EBITDA | · | -18.5 | · | -9.2 | -2.8 | · | · | · | · | · | · | · | · | · | · | -6.1 | |
| EV / Revenue | · | 21.3 | · | 5.4 | 2.0 | · | · | · | · | · | · | · | · | · | · | 57.0 | |
| Earnings Yield | -30.7% | -29.9% | · | -54.5% | -101.1% | -114.3% | · | -48.1% | -37.9% | -27.9% | · | -14.6% | -22.8% | -29.3% | · | -53.2% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $14M | $11M | $19M | $40M | $589.0K |
| Betriebsgewinnmarge % | -271.9% | -564.7% | -55.5% | 45.7% | -3854.8% |
| Nettoergebnis | $-50M | $-58M | $-10M | $18M | $-57M |
| Verwässerte EPS | $-0.80 | $-2.15 | $-0.46 | $0.87 | $-3.82 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.1 | — | — | 0.0 | 0.0 |
| Liquiditätsgrad | 6.4 | 3.2 | 13.3 | 17.8 | 6.8 |
| Quick Ratio | 6.1 | 3.0 | 12.7 | 16.0 | 0.1 |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 104 Einreicher · $216.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 41 (+17 vs. Vorquartal) | 14 (+8 vs. Vorquartal) | 30 (+13 vs. Vorquartal) | 14 (0 vs. Vorquartal) | +11.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Caligan Partners LP | $24.976.815 | 6.077.084 | 11,53% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $24.782.375 | 6.029.775 | 11,44% | Aktien |
| BIOS Capital Management, LP | $15.138.893 | 3.683.429 | 6,99% | Aktien |
| Balyasny Asset Management L.P. | $12.691.129 | 3.087.866 | 5,86% | Aktien |
| Nantahala Capital Management, LLC | $12.582.185 | 3.061.359 | 5,81% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.160.187 | 2.958.683 | 5,61% | Aktien |
| Boxer Capital Management, LLC | $11.569.650 | 2.815.000 | 5,34% | Aktien |
| Trails Edge Capital Partners, LP | $11.276.434 | 2.743.658 | 5,21% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $9.461.635 | 2.302.101 | 4,37% | Aktien |
| GREAT POINT PARTNERS LLC | $8.097.469 | 1.970.187 | 3,74% | Aktien |
| ADAR1 Capital Management, LLC | $7.331.340 | 1.783.781 | 3,38% | Aktien |
| MARSHALL WACE, LLP | $7.238.709 | 1.761.243 | 3,34% | Aktien |
| Woodline Partners LP | $5.896.670 | 1.434.713 | 2,72% | Aktien |
| GOLDMAN SACHS GROUP INC | $5.871.460 | 1.428.579 | 2,71% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $4.888.907 | 1.189.515 | 2,26% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.730.097 | 1.150.478 | 2,18% | Aktien |
| Opaleye Management Inc. | $4.623.750 | 1.125.000 | 2,13% | Aktien |
| SummitTX Capital, L.P. | $4.140.213 | 1.007.351 | 1,91% | Aktien |
| STATE STREET CORP | $3.247.459 | 790.136 | 1,50% | Aktien |
| Bleichroeder LP | $3.028.421 | 736.842 | 1,40% | Aktien |
| UBS Group AG | $2.759.951 | 671.521 | 1,27% | Aktien |
| CITADEL ADVISORS LLC | $2.362.231 | 574.752 | 1,09% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.686.641 | 410.375 | 0,78% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.528.715 | 371.950 | 0,71% | Aktien |
| Squarepoint Ops LLC | $1.359.518 | 330.783 | 0,63% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.043.784 | 253.962 | 0,48% | Aktien |
| AWM Investment Company, Inc. | $955.945 | 232.590 | 0,44% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $809.247 | 196.897 | 0,37% | Aktien |
| JANE STREET GROUP, LLC | $776.741 | 188.988 | 0,36% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $678.368 | 165.053 | 0,31% | Aktien |
| Mink Brook Asset Management LLC | $662.553 | 161.205 | 0,31% | Aktien |
| XTX Topco Ltd | $592.230 | 144.095 | 0,27% | Aktien |
| Seven Fleet Capital Management LP | $588.293 | 143.137 | 0,27% | Aktien |
| VANGUARD GROUP INC | $537.964 | 267.644 | 0,25% | Aktien |
| Creative Planning | $527.584 | 128.366 | 0,24% | Aktien |
| Stonepine Capital Management, LLC | $413.951 | 100.718 | 0,19% | Aktien |
| Jump Financial, LLC | $389.711 | 94.820 | 0,18% | Aktien |
| Nuveen, LLC | $293.220 | 71.343 | 0,14% | Aktien |
| Palogic Value Management, L.P. | $267.512 | 65.088 | 0,12% | Aktien |
| Aureus Asset Management, LLC | $239.202 | 58.200 | 0,11% | Aktien |
| Regency Capital Management Inc.\DE | $238.380 | 58.000 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $211.512 | 51.464 | 0,10% | Aktien |
| EntryPoint Capital, LLC | $209.129 | 50.883 | 0,10% | Aktien |
| WELLS FARGO & COMPANY/MN | $200.765 | 48.848 | 0,09% | Aktien |
| Quadrature Capital Ltd | $190.659 | 46.389 | 0,09% | Aktien |
| Empowered Funds, LLC | $172.887 | 42.065 | 0,08% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $172.887 | 42.065 | 0,08% | Aktien |
| MANGROVE PARTNERS IM, LLC | $171.457 | 41.717 | 0,08% | Aktien |
| MORGAN STANLEY | $136.353 | 33.176 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $132.375 | 32.208 | 0,06% | Aktien |
| CAPTRUST FINANCIAL ADVISORS | $131.520 | 32.000 | 0,06% | Aktien |
| Bank of New York Mellon Corp | $127.558 | 31.036 | 0,06% | Aktien |
| BANK OF AMERICA CORP /DE/ | $127.204 | 30.950 | 0,06% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $115.479 | 25.380 | 0,05% | Aktien |
| CITIGROUP INC | $110.978 | 27.002 | 0,05% | Aktien |
| Miller Financial Services LLC | $110.970 | 27.000 | 0,05% | Aktien |
| SIMPLEX TRADING, LLC | $105.022 | 25.553 | 0,05% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $101.340 | 24.657 | 0,05% | Aktien |
| JPMORGAN CHASE & CO | $90.128 | 22.199 | 0,04% | Aktien |
| Invesco Ltd. | $87.761 | 21.353 | 0,04% | Aktien |
| JANE STREET GROUP, LLC | $84.666 | 20.600 | 0,04% | Kaufoption |
| Point72 Asset Management, L.P. | $77.769 | 18.922 | 0,04% | Aktien |
| BlackRock, Inc. | $76.705 | 18.663 | 0,04% | Aktien |
| JAMES INVESTMENT RESEARCH, INC. | $67.256 | 16.364 | 0,03% | Aktien |
| NewEdge Advisors, LLC | $67.256 | 16.364 | 0,03% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $65.550 | 15.949 | 0,03% | Aktien |
| State of Wyoming | $65.365 | 15.904 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $64.909 | 15.793 | 0,03% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $61.683 | 15.008 | 0,03% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $59.595 | 14.500 | 0,03% | Aktien |
| Vanguard Global Advisers, LLC | $58.946 | 14.342 | 0,03% | Aktien |
| OSAIC HOLDINGS, INC. | $57.128 | 13.900 | 0,03% | Aktien |
| KESTRA PRIVATE WEALTH SERVICES, LLC | $52.608 | 12.800 | 0,02% | Aktien |
| Stokes Family Office, LLC | $49.813 | 12.120 | 0,02% | Aktien |
| Engineers Gate Manager LP | $49.579 | 12.063 | 0,02% | Aktien |
| First City Capital Management, Inc. | $48.646 | 11.836 | 0,02% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $47.536 | 11.566 | 0,02% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $45.280 | 11.017 | 0,02% | Aktien |
| STRS OHIO | $43.155 | 10.500 | 0,02% | Aktien |
| BARCLAYS PLC | $37.261 | 9.066 | 0,02% | Aktien |
| NORTHERN TRUST CORP | $34.606 | 8.420 | 0,02% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $33.624 | 8.181 | 0,02% | Aktien |
| COMERICA BANK | $24.120 | 12.000 | 0,01% | Aktien |
| Texas Capital Bank Wealth Management Services Inc | $22.724 | 5.529 | 0,01% | Aktien |
| Legal & General Group Plc | $21.384 | 5.203 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $19.975 | 4.860 | 0,01% | Aktien |
| Hilton Head Capital Partners, LLC | $18.380 | 4.472 | 0,01% | Aktien |
| Russell Investments Group, Ltd. | $17.599 | 4.282 | 0,01% | Aktien |
| Farther Finance Advisors, LLC | $14.344 | 3.490 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $13.053 | 3.176 | 0,01% | Aktien |
| TD Waterhouse Canada Inc. | $12.528 | 3.000 | 0,01% | Aktien |
| NATIONAL BANK OF CANADA /FI/ | $8.278 | 2.014 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $7.000 | 1.754 | 0,00% | Aktien |
| DEUTSCHE BANK AG\ | $4.402 | 1.071 | 0,00% | Aktien |
| GGM Financial LLC | $4.131 | 1.005 | 0,00% | Aktien |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $2.178 | 521 | 0,00% | Aktien |
| Quarry LP | $2.063 | 502 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $2.059 | 501 | 0,00% | Aktien |
| Sterling Capital Management LLC | $773 | 188 | 0,00% | Aktien |
| FMR LLC | $584 | 142 | 0,00% | Aktien |
Unternehmensinsider 45 Insider · 17 Führungskräfte · 31 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| George Magrath | Chief Executive Officer | 23. Juli 2026 S | 1.731.869 | 0 | 3 | $-204.920 |
| Sooch Mina | President and CEO | 10. Januar 2023 A | 430.501 | 0 | 0 | $0 |
| Douglas J Swirsky | President and CEO | 29. Januar 2019 P | 50.000 | 0 | 0 | $0 |
| Peter David Suzdak | Chief Executive Officer | 28. Februar 2018 M | 22.250 | 0 | 0 | $0 |
| Robert E. Gagnon | Chief Financial Officer | 23. Juli 2026 S | 584.375 | 0 | 2 | $-63.582 |
| Nirav S. Jhaveri | Chief Financial Officer | 13. März 2025 A | 194.293 | 0 | 0 | $0 |
| Tae Heum Jeong | Chief Financial Officer | 20. Januar 2017 A | 505.000 | 0 | 0 | $0 |
| Benjamin R Yerxa | President | 23. Juli 2026 S | 704.106 | 0 | 2 | $-61.207 |
| Rakesh Soni | President and COO | 12. Januar 2014 A | — | 0 | 0 | $0 |
| Joseph K Schachle | Chief Operating Officer | 23. Juli 2026 S | 291.440 | 0 | 3 | $-57.696 |
| Ashwath Jayagopal | Chief Scientific & Dev. Ofc. | 23. April 2026 S | 509.233 | 0 | 2 | $-58.184 |
| Rabourn Amy Zaremba | Head of Fin. Quality Assurance | 23. April 2026 S | 188.671 | 0 | 2 | $-23.289 |
| Bernhard Hoffmann | SVP of Corp. Dev. | 13. März 2025 A | 185.446 | 0 | 0 | $0 |
| Ronil A. Patel | Chief Business Officer | 10. Januar 2024 F | 90.714 | 0 | 0 | $0 |
| Lisa Nolan | Chief Business Officer | 28. Februar 2019 M | 23.250 | 0 | 0 | $0 |
| Ely Benaim | Chief Medical Officer | 28. Februar 2019 M | 4.750 | 0 | 0 | $0 |
| George F Steinfels | Chief Business Officer Sr. VP | 8. Dezember 2005 A | — | 0 | 0 | $0 |
| Jean Bennett | Direktor | 20. April 2026 A | 259.019 | 0 | 0 | $0 |
| Sean Ainsworth | Direktor | 20. April 2026 A | 321.692 | 0 | 0 | $0 |
| Cam Gallagher | Direktor | 20. April 2026 A | 2.015.797 | 2 | 0 | $323.890 |
| Susan Benton | Direktor | 20. April 2026 A | 243.894 | 0 | 0 | $0 |
| Adrienne L Graves | Direktor | 20. April 2026 A | 127.514 | 0 | 0 | $0 |
| Richard J Rodgers | Direktor | 20. April 2026 A | 343.022 | 0 | 0 | $0 |
| James S J Manuso | Direktor | 20. April 2026 A | 317.318 | 0 | 0 | $0 |
| Jay Pepose | Direktor | 11. Juni 2024 A | 180.458 | 0 | 0 | $0 |
| Lara Sullivan, M.D. | Direktor | 6. Juni 2019 A | — | 0 | 0 | $0 |
| Peter C. Brandt | Direktor | 6. Juni 2019 A | 150.000 | 0 | 0 | $0 |
| Ben Gil Price | Direktor | 6. Juni 2019 A | 15.000 | 0 | 0 | $0 |
| Charles Beever | Direktor | 6. Juni 2019 A | 11.000 | 0 | 0 | $0 |
| Kwang Soo Cheong | Direktor | 6. Juni 2019 A | 3.000 | 0 | 0 | $0 |
| Mark Carthy | Direktor | 11. April 2017 A | — | 0 | 0 | $0 |
| Chang Ho Ahn | Direktor | 10. April 2017 M | 6.010.000 | 0 | 0 | $0 |
| Si Moon Hwang | Direktor | 9. Juni 2014 A | — | 0 | 0 | $0 |
| David M Mcintosh | Direktor | 9. Juni 2014 A | 25.990 | 0 | 0 | $0 |
| Richard Kivel | Direktor | 18. Juni 2012 A | 2.500 | 0 | 0 | $0 |
| Freddie Ann Hoffman | Direktor | 1. Juni 2009 A | 1.000 | 0 | 0 | $0 |
| Michele Y Kang | Direktor | 1. Juni 2009 A | 10.000 | 0 | 0 | $0 |
| Young Soon Park | Direktor | 11. Dezember 2006 G | 2.040.500 | 0 | 0 | $0 |
| John W Holaday DR | Direktor | 2. Mai 2006 A | — | 0 | 0 | $0 |
| Inok Ahn | Direktor | 8. Dezember 2005 A | — | 0 | 0 | $0 |
| Jang Han Rhee | Direktor | 13. Mai 2005 A | 2.000.000 | 0 | 0 | $0 |
| Suk Hyung Kwon | Direktor | 13. Mai 2005 A | 114.255 | 0 | 0 | $0 |
| Frank Ferraro | Direktor | 11. Januar 2005 S | 0 | 0 | 0 | $0 |
| Rexgene Biotech Co., Ltd. | 10%-Eigentümer | 24. Dezember 2007 A | 5.505.956 | 0 | 0 | $0 |
| Alan R Meyer | — | 19. November 2020 P | 487.029 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 17 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund, Foundation Fighting Blindness, Inc. ×4 Einreichungen | 20. Mai 2026 | 4,66% | Änderung | — | SEC |
| Dr. Chang H. Ahn Not Applicable ×3 Einreichungen | 9. Oktober 2013 | — | Erste Einreichung | — | SEC |
| Dr. Chang H Ahn Not Applicable ×2 Einreichungen | 20. Mai 2011 | — | Erste Einreichung | — | SEC |
| Rexgene Biotech Co., Ltd. Not Applicable ×3 Einreichungen | 30. September 2009 | — | Erste Einreichung | Passive Anlage | SEC |
| KT&G Corporation Not Applicable ×2 Einreichungen | 26. Dezember 2007 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 23. Mai 2005 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 23. Mai 2005 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 23. Mai 2005 | — | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter | 23. Mai 2005 | — | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter | 23. Mai 2005 | — | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter | 23. Mai 2005 | — | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter | 23. Mai 2005 | — | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter | 23. Mai 2005 | — | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter | 23. Mai 2005 | — | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter | 21. Januar 2005 | — | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 9 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,41% | 25.647 SH | 8. August 2026 | Täglich |
| IWC · iShares Trust | 0,05% | 183.701 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 490.686 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 309.583 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 57.702 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 1.321.362 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 652.278 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.239.388 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.665 SH | 8. August 2026 | Täglich |